Recently, it has been observed that hypothyroidism is closely associated with NAFLD (Chung et al., 2012), and that thyrotropin increases hepatic triglyceride content through upregulation of SREBP-1c activity (Yan et al., 2014). This evidence concerns the gene SREBF1 and metabolic dysfunction-associated steatotic liver disease.